Aprofol

Aprofol is a Swiss biotechnology company specializing in the development and commercialization of bioactive folate derivatives. The company's core expertise lies in the production of [6S]-5-methyltetrahydrofolic acid and [6S]-5,10-methylene-tetrahydrofolic acid, which are the naturally occurring, active forms of folate. Aprofol's lead product, arfolitixorin (Modufolin), was licensed to Isofol Medical for the treatment of colorectal cancer and has undergone late-stage clinical development. Additionally, the company markets Ocufolin, a specialized medical food designed to support eye health in patients with age-related macular degeneration and diabetic retinopathy. Aprofol focuses on leveraging its proprietary folate technology to improve therapeutic outcomes in oncology and ophthalmology.